Clinical Trials Logo

Clinical Trial Details — Status: Terminated

Administrative data

NCT number NCT04786379
Other study ID # IRB #E21085
Secondary ID
Status Terminated
Phase N/A
First received
Last updated
Start date April 1, 2021
Est. completion date April 30, 2022

Study information

Verified date December 2023
Source Texas Tech University Health Sciences Center, El Paso
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Surgical excisional debridement is the mainstay of management in septic arthritis with necessary decompression, lavage, debridement, and partial synovectomy. However, there has been considerable debate over the optimal modality. Most surgeons perform an open arthrotomy or arthroscopic debridement, although serial aspiration can be considered as an option in very limited circumstances with patients who cannot tolerate surgery. While open arthrotomy has been often utilized, there has been an increasing number of proponents for arthroscopic treatment citing lower re-infection rates and better functional outcomes. However, there has been a lack of well-designed prospective studies comparing surgical treatment modalities for native knee septic arthritis. The goals of this present study are to determine if arthroscopic management of septic arthritis in the native knee resulted in a lower number of surgeries and a shorter length of stay compared to open arthrotomy. Secondary outcomes included differences in postoperative pain and improvements in Lysholm knee scores.


Recruitment information / eligibility

Status Terminated
Enrollment 10
Est. completion date April 30, 2022
Est. primary completion date April 30, 2022
Accepts healthy volunteers No
Gender All
Age group N/A and older
Eligibility Inclusion Criteria: - Adults (>18 years old) - Have a diagnosis of septic arthritis of the native knee (synovial WBC >50k or acrystalline elevated synovial WBC >25,000 with high clinical suspicion) - Willingness to participate in the study Exclusion Criteria: - Unwilling to participate in the study - Acrystalline elevated synovial WBC < 25,000 - Crystalline arthropathy with elevated synovial WBC but < 50,000 - Have a history of a prior knee prosthesis (hemiarthroplasty, total knee arthroplasty)

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
Arthroscopic Irrigation and Debridement
Patients with confirmed septic arthritis treated with multiple small incisions to perform irrigation and debridement with partial synovectomy.
Open Arthrotomy with irrigation and debridement
Patients with confirmed septic arthritis treated with a single large incision, open arthrotomy to perform irrigation and debridement with partial synovectomy.

Locations

Country Name City State
United States University Medical Center of El Paso El Paso Texas

Sponsors (1)

Lead Sponsor Collaborator
Texas Tech University Health Sciences Center, El Paso

Country where clinical trial is conducted

United States, 

References & Publications (4)

Aim F, Delambre J, Bauer T, Hardy P. Efficacy of arthroscopic treatment for resolving infection in septic arthritis of native joints. Orthop Traumatol Surg Res. 2015 Feb;101(1):61-4. doi: 10.1016/j.otsr.2014.11.010. Epub 2015 Jan 23. — View Citation

Bohler C, Dragana M, Puchner S, Windhager R, Holinka J. Treatment of septic arthritis of the knee: a comparison between arthroscopy and arthrotomy. Knee Surg Sports Traumatol Arthrosc. 2016 Oct;24(10):3147-3154. doi: 10.1007/s00167-015-3659-8. Epub 2015 May 28. — View Citation

Hunter JG, Gross JM, Dahl JD, Amsdell SL, Gorczyca JT. Risk factors for failure of a single surgical debridement in adults with acute septic arthritis. J Bone Joint Surg Am. 2015 Apr 1;97(7):558-64. doi: 10.2106/JBJS.N.00593. — View Citation

Wirtz DC, Marth M, Miltner O, Schneider U, Zilkens KW. Septic arthritis of the knee in adults: treatment by arthroscopy or arthrotomy. Int Orthop. 2001;25(4):239-41. doi: 10.1007/s002640100226. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Number of surgeries to obtain lasting clinical resolution The total number of surgeries performed during initial admission in order to obtain appropriate clinical response and resultant discharge on outpatient antibiotics. Through time period of initial admission (days; expected under 14 days)
Primary Hospital length of stay The total number of days in which the patient is initially admitted in order to obtain appropriate clinical response and resultant discharge on outpatient antibiotics. Through time period of initial admission (days; expected under 14 days)
Secondary Post Operative Pain Scores Daily morning and afternoon visual analogue scale reported by nursing staff. This value is reported on a scale of 0-10; a score of 0 indicates no pain while 10 indicates unbearable pain Through time period of initial admission (days; expected under 14 days)
Secondary Post Operative Opioid Use All patients will have post operative pain medications which are to be utilized in a step wise manner for treating their pain. For example, if they are in minimal pain they will be given tylenol whereas unbearable pain will be treated with opioid analgesics. The average total post-operative opioid usage during initial admission will be reported as total morphine milligram equivalent. Through time period of initial admission (days; expected under 14 days)
Secondary Lysholm Knee Scale The Lysholm score is a 100-point scoring system for examining a patient's knee-specific symptoms including mechanical locking, instability, pain, swelling, stair climbing, and squatting. The scoring is between 0-100 points. A score of <65 indicates poor knee function, 65-83 indicates fair knee function, 84-94 indicates a fair outcome, and 95-100 indicates excellent knee function. This scoring system will be obtained at 2 week, 6 week, and 3 months. Through anticipated follow up period of 3 month post operative appointment.
See also
  Status Clinical Trial Phase
Not yet recruiting NCT06003374 - Extended Hip Ultrasound as Anew Protocol for Septic Hip in Children
Active, not recruiting NCT04563325 - Oral-only Antibiotics for Bone and Joint Infections in Children Phase 4
Recruiting NCT05341908 - Prevalence of Pathogens in Synovial Fluid Obtained From Emergency Department Patients
Completed NCT03846804 - Next-Generation Sequencing for Pathogen Detection and Quantification in Children With Musculoskeletal Infections N/A
Completed NCT00503438 - Ankle Joint Replacement Outcomes Study
Recruiting NCT04952220 - Exploratory Study of Ultrasound Signs of Native Septic Arthritis of the Knee
Active, not recruiting NCT02565160 - Analysis of Human Knee Joint Fluid Using Metabonomic, Genomic and Tribology Techniques
Recruiting NCT05971745 - Accuracy of Pediatric Emergency Medicine Providers in Diagnosing Hip Effusions Using Point of Care Ultrasound
Completed NCT05593874 - Predictive Value of Nu.Q™ Biomarkers to Help Guiding the Management of Osteoarticular Infections
Recruiting NCT02530229 - Arthrocentesis Study N/A
Not yet recruiting NCT05521880 - Anchoring Sequential Intermittent Long Acting Antimicrobials With Medication for Opioid Use Disorder (MOUD) for Invasive Infections Related to Opioid Use Phase 4
Completed NCT03802552 - Cefadroxil and Cephalexin Drug Levels and Dosing in Pediatric Musculoskeletal Infections Phase 1
Not yet recruiting NCT05780697 - Short Term Results of Pediatric Septic Hip Arthritis Management in Assiut University Hospitals N/A
Recruiting NCT03704766 - Alpha-Defensin and Synovial Proteins to Improve Detection of Pediatric Septic Arthritis N/A
Not yet recruiting NCT05886166 - Clinical Utility of Exoskeleton Robot Training in Patients With Septic Arthritis After a Thermal Injury: A Case Report N/A
Recruiting NCT04538053 - BonE and Joint Infections - Simplifying Treatment in Children Trial Phase 4
Recruiting NCT04141787 - Ceftriaxone as Home IV for Staph Infections Phase 4
Completed NCT06241365 - The Predictive Role of C-reactive Protein to Albumin Ratio (CAR) in the Treatment of Septic Arthritis in Young Chlidren
Completed NCT03426761 - Dalbavancin For The Treatment of Gram Positive Osteoarticular Infections Phase 4
Completed NCT02018952 - Ultrasonography Assessment of Septic Arthritis on Native Joint N/A